Logo image of PRFX

PAINREFORM LTD (PRFX) Stock Price, Quote, News and Overview

NASDAQ:PRFX - Nasdaq - IL0011651580 - Common Stock - Currency: USD

3.06  +0.08 (+2.68%)

PRFX Quote, Performance and Key Statistics

PAINREFORM LTD

NASDAQ:PRFX (3/7/2025, 8:00:01 PM)

3.06

+0.08 (+2.68%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High61.2
52 Week Low1.73
Market Cap2.66M
Shares870.00K
Float850.00K
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-13 2025-05-13
IPO09-01 2020-09-01


PRFX short term performance overview.The bars show the price performance of PRFX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

PRFX long term performance overview.The bars show the price performance of PRFX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PRFX is 3.06 USD. In the past year, price decreased by -93.56%.

PAINREFORM LTD / PRFX Daily stock chart

PRFX Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 66.89 824.51B
JNJ JOHNSON & JOHNSON 16.69 401.33B
NVO NOVO-NORDISK A/S-SPONS ADR 26.34 386.95B
AZN ASTRAZENECA PLC-SPONS ADR 21.41 240.28B
MRK MERCK & CO. INC. 12.39 239.09B
NVS NOVARTIS AG-SPONSORED ADR 14.56 228.26B
PFE PFIZER INC 8.59 151.49B
SNY SANOFI-ADR 14.31 148.55B
BMY BRISTOL-MYERS SQUIBB CO 53.59 123.97B
GSK GSK PLC-SPON ADR 8.34 81.62B
ZTS ZOETIS INC 28.78 76.29B
TAK TAKEDA PHARMACEUTIC-SP ADR 33.71 47.88B

About PRFX

Company Profile

PRFX logo image PainReform Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.

Company Info

PAINREFORM LTD

65 Yigal Alon St.

TEL AVIV-YAFO 6745442 IL

CEO: Ilan Hadar

Employees: 7

Company Website: https://painreform.com/

Investor Relations: http://painreform.com/investors

Phone: 97237177051

PAINREFORM LTD / PRFX FAQ

What is the stock price of PAINREFORM LTD today?

The current stock price of PRFX is 3.06 USD. The price increased by 2.68% in the last trading session.


What is the ticker symbol for PAINREFORM LTD stock?

The exchange symbol of PAINREFORM LTD is PRFX and it is listed on the Nasdaq exchange.


On which exchange is PRFX stock listed?

PRFX stock is listed on the Nasdaq exchange.


What is PAINREFORM LTD worth?

PAINREFORM LTD (PRFX) has a market capitalization of 2.66M USD. This makes PRFX a Nano Cap stock.


How many employees does PAINREFORM LTD have?

PAINREFORM LTD (PRFX) currently has 7 employees.


What are the support and resistance levels for PAINREFORM LTD (PRFX) stock?

PAINREFORM LTD (PRFX) has a support level at 3.02 and a resistance level at 3.06. Check the full technical report for a detailed analysis of PRFX support and resistance levels.


Should I buy PAINREFORM LTD (PRFX) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PAINREFORM LTD (PRFX) stock pay dividends?

PRFX does not pay a dividend.


When does PAINREFORM LTD (PRFX) report earnings?

PAINREFORM LTD (PRFX) will report earnings on 2025-05-13.


What is the Price/Earnings (PE) ratio of PAINREFORM LTD (PRFX)?

PAINREFORM LTD (PRFX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-179.76).


What is the Short Interest ratio of PAINREFORM LTD (PRFX) stock?

The outstanding short interest for PAINREFORM LTD (PRFX) is 4% of its float. Check the ownership tab for more information on the PRFX short interest.


PRFX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PRFX Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to PRFX. PRFX has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

PRFX Financial Highlights

Over the last trailing twelve months PRFX reported a non-GAAP Earnings per Share(EPS) of -179.76. The EPS decreased by -1758.81% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -568.81%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-1336.27%
Sales Q2Q%N/A
EPS 1Y (TTM)-1758.81%
Revenue 1Y (TTM)N/A

PRFX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 43% to PRFX. The Buy consensus is the average rating of analysts ratings from 6 analysts.


Ownership
Inst Owners4.97%
Ins OwnersN/A
Short Float %4%
Short Ratio0.01
Analysts
Analysts43.33
Price TargetN/A
EPS Next Y51.55%
Revenue Next YearN/A